Skip to main content

Table 3 Phosphate change rates compared to patient baseline

From: Comparative analysis of the phosphate-binding effects of sucroferric oxyhydroxide, ferric citrate, and lanthanum carbonate

FC Estimate % Standard Error p SF Estimate % Standard Error p LC Estimate % Standard Error p
Total vs BaseLine −1.10 1.86 0.56 Total vs BaseLine −3.33 1.48 0.03* Total vs BaseLine −5.36 1.76 0.00*
1 3.16 2.78 0.26 1 1.78 2.43 0.46 1 −0.30 2.46 0.90*
2 1.60 2.78 0.57 2 3.78 2.43 0.12 2 −5.63 2.46 0.02*
3 −1.17 2.78 0.67 3 2.50 2.43 0.30 3 −7.37 2.46 0.00
4 1.18 2.78 0.67 4 2.58 2.43 0.29 4 −4.27 2.46 0.08*
5 −2.89 2.78 0.30 5 2.25 2.43 0.35 5 −6.85 2.46 0.01*
6 −4.08 2.78 0.14 6 5.50 2.43 0.02* 6 −6.92 2.46 0.01*
7 −5.21 2.78 0.06 7 5.61 2.43 0.02* 7 −5.39 2.46 0.03
8 −0.48 2.78 0.86 8 1.10 2.43 0.65 8 −4.80 2.46 0.05
9 −2.36 2.78 0.40 9 1.98 2.43 0.41 9 −3.24 2.46 0.19*
10 −3.12 2.78 0.26 10 −1.11 2.43 0.65 10 −8.79 2.46 0.00*
11 −4.59 2.78 0.10 11 −6.89 2.43 0.00* 11 −6.30 2.46 0.01*
12 −6.69 2.78 0.02* 12 −7.04 2.43 0.00* 12 −5.12 2.46 0.04*
13 −1.26 2.78 0.65 13 −9.88 2.43 <.0001* 13 −7.31 2.46 0.00*
14 −3.11 2.78 0.26 14 −12.61 2.43 <.0001* 14 −12.02 2.46 <.0001*
15 −0.95 2.78 0.73 15 −10.24 2.43 <.0001* 15 −9.00 2.46 0.00*
16 −1.11 2.78 0.69 16 −11.48 2.43 <.0001* 16 −5.68 2.46 0.02*
17 0.37 2.78 0.90 17 −7.65 2.43 0.00* 17 −5.56 2.46 0.02
18 −1.91 2.78 0.49 18 −7.61 2.43 0.00* 18 −4.04 2.46 0.10*
19 −1.06 2.78 0.70 19 −10.30 2.43 <.0001* 19 −6.23 2.46 0.01
20 0.63 2.78 0.82 20 −10.35 2.43 <.0001* 20 −4.79 2.46 0.05
21 2.81 2.78 0.31 21 −11.33 2.43 <.0001* 21 −4.35 2.46 0.08
  1. * p < 0.05; SE standard error